Center for Leukodystrophies

For more than 30 years, Kennedy Krieger Institute has been globally recognized as an authority on the study and care for patients diagnosed with a wide range of leukodystrophies. This international reputation is thanks to the lasting legacy of the late Dr. Hugo W. Moser, one of the world’s foremost leaders in the field of leukodystrophies.

Dr. Moser’s visionary thinking and belief that innovative research should enhance clinical care had a profound impact on his patients, peers, and generations of former trainees, who remain highly dedicated to improving the lives of individuals with leukodystrophies worldwide.

Today, that commitment continues--through the Moser Center for Leukodystrophies at Kennedy Krieger where leading edge techniques in neuroimaging, genomics, biomedical engineering, and nanotechnology help our experts to enhance understanding, diagnosis, and treatment.

The center provides comprehensive care to patients with leukodystrophies through an interdisciplinary approach, bringing together the fields of neurogenetics, genetic counseling, neurorehabilitation, endocrinology, and urology, along with physical, occupational, speech, and aquatic therapy. Following in Dr Moser’s footsteps, the center works collaboratively with other leukodystrophy centers across the country and around the world to ensure that each and every patient receives the best possible care.

Our Mission:

Our mission is to improve the care of individuals affected by a leukodystrophy from early childhood to late adulthood.

Our Vision:

Our vision is to combine cutting edge techniques in neuroimaging, genomics, biomedical engineering, and nanotechnology to develop new diagnostic tools and novel therapeutics for leukodystrophies. Furthermore, we aspire to provide the best possible comprehensive care to patients with leukodystrophies through an interdisciplinary approach.

Primary Diagnoses Served:

• Adrenoleukodystrophy 
• Alexander Disease
• Canavan Disease
• Cerebrotendinous Xanthomatosis
• Krabbe Disease (globoid cell leukodystrophy)
• Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL)
• Metachromatic Leukodystrophy
• Pelizaeus-Merzbacher Disease
• Vanishing White Matter Leukodystrophy
• Hypomyelinating Disorders
• Undiagnosed Leukodystrophies

The Moser Center for Leukodystrophies is a Leukodystrophy Care Network (LCN) Center, meeting or exceeding the criteria for LCN Certification. The Leukodystrophy Care Network (LCN) is a community of affected families, organizations and medical providers committed to revolutionizing the health and quality of life of individuals affected by Leukodystrophies with proactive, innovative, and comprehensive medical care standards and specialized centers. To learn more, please visit the LCN website.